세계의 바이오 제염 시장 - 규모, 점유율, 동향 분석 보고서 : 성분별, 약제별, 유형별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Bio Decontamination Market Size & Trends

The global bio decontamination market size was estimated at USD 222.96 million in 2023 and is expected to grow at a CAGR of 8.62% from 2024 to 2030. Market growth can be attributed to the increasing number of surgical procedures, growth in the healthcare & pharmaceutical/biotechnology industries, and rising incidence of Hospital-Acquired Infections (HAIs). According to the WHO, in high-income countries, 7 out of every 100 patients in acute-care hospitals acquire at least one HAI; in low- and middle-income countries, this number is 15 of 100. On average, 1 out of every 10 patients affected by an HAI will die from it during their hospital stay. This alarming trend has heightened the need for stringent bio decontamination measures in healthcare facilities.

The growing prevalence of cancer & other chronic diseases, the rapidly aging population, and advancements in medical technology have led to a rise in the number of surgical procedures. This trend has increased the demand for these services to ensure the sterility and safety of equipment & facilities. The rise in surgical procedures has heightened the need for stringent bio decontamination measures to maintain sterile operating rooms, equipment, and facilities. This drives the demand for bio decontamination services and technologies to prevent surgical-site infections & ensure patient safety. The growth of the healthcare, pharmaceutical, and biotechnology industries has significantly driven the market. These sectors require meticulous decontamination protocols to maintain sterile, contamination-free environments, including R&D & manufacturing processes.

Hydrogen-peroxide-based decontamination equipment has become increasingly prevalent in these industries. For instance, in May 2022, Bionova Capital announced that Delox, a company in its portfolio, raised an additional EUR 750,000, bringing its total capital to over EUR 1.3 million. This investment, supported by Bionova Capital, Caixa Capital, Kiilto Ventures, and a Portuguese family office, would help Delox launch its patented antimicrobial system. Delox's proprietary bio decontamination system can remove 99.9999% of all microbial entities, such as bacteria and viruses, from lab equipment & work areas.

Governments and regulatory agencies worldwide are enforcing more stringent rules and guidelines regarding bio decontamination procedures, especially in healthcare, pharmaceutical manufacturing, & food processing. Compliance with these regulations has compelled organizations to adopt advanced decontamination methods and technologies to ensure the safety and sterility of their facilities & products. For instance, the U.S. Environmental Protection Agency (EPA) regulates disinfectants and sterilants under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). In addition, the U.S. FDA provides guidelines for validating and monitoring sterilization processes for medical devices.

Bio decontamination Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global Bio decontamination market report based on component, agent, type, end-use, and region.

• Component Outlook (Revenue, USD Million, 2018 - 2030)
• Equipment
• Services
• Consumables
• Agent Outlook (Revenue, USD Million, 2018 - 2030)
• Hydrogen Peroxide
• Chlorine Dioxide
• Peracetic Acid
• Nitrogen Dioxide
• Type Outlook (Revenue, USD Million, 2018 - 2030)
• Chamber Decontamination
• Room Decontamination
• End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Biotech Companies & Research Organizations
• Pharmaceutical & Medical Device Manufacturers
• Life science Laboratories & Research Organizations
• Hospital & Other Healthcare Facilities
• Food & Beverage Companies
• Others
• Regional Outlook (Revenue in USD Million, 2018 - 2030)
• North America

U.S.

Canada

Mexico

• Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

• Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

• Latin America

Brazil

Argentina

• Middle East and Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Component
  • 1.2.2. Agent
  • 1.2.3. Type
  • 1.2.4. End-use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Bio decontamination Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing number of surgical procedures
    • 3.2.1.2. Growth in the healthcare sector and pharmaceutical/biotechnology industries
    • 3.2.1.3. Rising incidence of hospital acquired infections (HAIs)
    • 3.2.1.4. Government and regulatory agencies
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Regulatory hurdles and stringent guidelines
    • 3.2.2.2. Environmental concerns related to the disposal of bio decontamination waste
• 3.3. Bio decontamination Market Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis

Chapter 4. Bio decontamination Market: Component Estimates & Trend Analysis

• 4.1. Global Bio decontamination Market: Component Dashboard
• 4.2. Global Bio decontamination Market: Component Analysis
• 4.3. Global Bio decontamination Market by Component, Revenue
• 4.4. Equipment
  • 4.4.1. Equipment market estimates and forecasts 2018 to 2030, (USD Million)
• 4.5. Services
  • 4.5.1. Services market estimates and forecasts 2018 to 2030, (USD Million)
• 4.6. Consumables
  • 4.6.1. Consumables market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 5. Bio decontamination Market: Agent Estimates & Trend Analysis

• 5.1. Global Bio decontamination Market: Agent Dashboard
• 5.2. Global Bio decontamination Market: Agent Movement Analysis
• 5.3. Global Bio decontamination Market Estimates and Forecasts, By Agent, Revenue (USD Million)
• 5.4. Hydrogen Peroxide
  • 5.4.1. Hydrogen Peroxide market estimates and forecasts 2018 to 2030, (USD Million)
• 5.5. Chlorine Dioxide
  • 5.5.1. Chlorine Dioxide market estimates and forecasts 2018 to 2030, (USD Million)
• 5.6. Peracetic Acid
  • 5.6.1. Peracetic Acid market estimates and forecasts 2018 to 2030, (USD Million)
• 5.7. Nitrogen Dioxide
  • 5.7.1. Nitrogen Dioxide market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 6. Bio decontamination Market: Type Estimates & Trend Analysis

• 6.1. Global Bio decontamination Market: Type Dashboard
• 6.2. Global Bio decontamination Market: Type Movement Analysis
• 6.3. Global Bio decontamination Market Estimates and Forecasts, By Type, Revenue (USD Million)
• 6.4. Chamber Decontamination
  • 6.4.1. Chamber Decontamination market estimates and forecasts 2018 to 2030, (USD Million)
• 6.5. Room Decontamination
  • 6.5.1. Room Decontamination market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 7. Bio decontamination Market: End-use Estimates & Trend Analysis

• 7.1. Global Bio decontamination Market: End-use Dashboard
• 7.2. Global Bio decontamination Market: End-use Movement Analysis
• 7.3. Global Bio decontamination Market Estimates and Forecasts, By End-use, Revenue (USD Million)
• 7.4. Biotech Companies & Research Organizations
  • 7.4.1. Biotech Companies & Research Organizations Market Estimates and Forecasts 2018 to 2030, (USD Million)
• 7.5. Pharmaceuticals & Medical Devices Manufacturers
  • 7.5.1. Pharmaceuticals & Medical Devices Manufacturers Market Estimates and Forecasts 2018 to 2030, (USD Million)
• 7.6. Life science Laboratories & Research Organizations
  • 7.6.1. Life science Laboratories & Research Organizations Market Estimates and Forecasts 2018 to 2030, (USD Million)
• 7.7. Hospitals & Other Healthcare Facilities
  • 7.7.1. Hospitals & Other Healthcare Facilities Market Estimates and Forecasts 2018 to 2030, (USD Million)
• 7.8. Food & Beverage Companies
  • 7.8.1. Food & Beverage Companies Market Estimates and Forecasts 2018 to 2030, (USD Million)
• 7.9. Others
  • 7.9.1. Others Market Estimates and Forecasts 2018 to 2030, (USD Million)

Chapter 8. Bio decontamination Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework/reimbursement structure
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030, (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030, (USD Million)
  • 8.3.3. Mexico
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Regulatory framework/reimbursement structure
    • 8.3.3.3. Competitive scenario
    • 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030, (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework/reimbursement structure
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts 2018 to 2030, (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030, (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts 2018 to 2030, (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030, (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Vendor Landscape
  • 9.2.1. List of key distributors and channel partners
  • 9.2.2. Key customers
  • 9.2.3. Key company market share analysis, 2023
  • 9.2.4. Amira Srl
    • 9.2.4.1. Company overview
    • 9.2.4.2. Financial performance
    • 9.2.4.3. Product benchmarking
    • 9.2.4.4. Strategic initiatives
  • 9.2.5. ClorDiSys Solutions Inc
    • 9.2.5.1. Company overview
    • 9.2.5.2. Financial performance
    • 9.2.5.3. Product benchmarking
    • 9.2.5.4. Strategic initiatives
  • 9.2.6. Ecolab
    • 9.2.6.1. Company overview
    • 9.2.6.2. Financial performance
    • 9.2.6.3. Product benchmarking
    • 9.2.6.4. Strategic initiatives
  • 9.2.7. Fedegari Autoclavi S.p.A.
    • 9.2.7.1. Company overview
    • 9.2.7.2. Financial performance
    • 9.2.7.3. Product benchmarking
    • 9.2.7.4. Strategic initiatives
  • 9.2.8. Howorth Air Technology Limited
    • 9.2.8.1. Company overview
    • 9.2.8.2. Financial performance
    • 9.2.8.3. Product benchmarking
    • 9.2.8.4. Strategic initiatives
  • 9.2.9. JCE BIOTECHNOLOGY
    • 9.2.9.1. Company overview
    • 9.2.9.2. Financial performance
    • 9.2.9.3. Product benchmarking
    • 9.2.9.4. Strategic initiatives
  • 9.2.10. Noxilizer, Inc.
    • 9.2.10.1. Company overview
    • 9.2.10.2. Financial performance
    • 9.2.10.3. Product benchmarking
    • 9.2.10.4. Strategic initiatives
  • 9.2.11. STERIS
    • 9.2.11.1. Company overview
    • 9.2.11.2. Financial performance
    • 9.2.11.3. Product benchmarking
    • 9.2.11.4. Strategic initiatives
  • 9.2.12. TOMI Environmental Solutions, Inc
    • 9.2.12.1. Company overview
    • 9.2.12.2. Financial performance
    • 9.2.12.3. Product benchmarking
    • 9.2.12.4. Strategic initiatives
  • 9.2.13. Zhejiang TAILIN Bioengineering Co., LTD
    • 9.2.13.1. Company overview
    • 9.2.13.2. Financial performance
    • 9.2.13.3. Product benchmarking
    • 9.2.13.4. Strategic initiatives